ImClone Systems Inc (formerly IMCL)

[upwestside]

fair enough and you make good points. maybe you can solve another dilemma for me: trial 025 met its primary endpoint against (what i understand to be) a difficult-to-beat BSC standard. form reading this board, BSC is supposed to be superior metric to PFS or OS (i dont remember which one) which was the endpoint in the pani mono trial. i know pani beat with very high stat sig but isnt demonstrating superiority to BSC a bigger accomplishment? if so, how could vecti take sales away from erb in mono setting? if BSC is not the metric i thought it was, then my question is how could erb demonstrate superiority to erb in this setting?

thanks.